Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol
; 25(7): 820-8, 2007 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-17159195
Search on Google
Database:
MEDLINE
Main subject:
Tamoxifen
/
Triazoles
/
Breast Neoplasms
/
Osteoporosis, Postmenopausal
/
Goserelin
/
Aromatase Inhibitors
/
Diphosphonates
/
Imidazoles
/
Antineoplastic Agents
/
Nitriles
Type of study:
Clinical_trials
/
Risk_factors_studies
Language:
En
Journal:
J Clin Oncol
Year:
2007
Type:
Article
Affiliation country:
Austria